/ /

Keith Loria
Keith Loria is a contributing writer to Medical Economics.
Rheumatologic side effects possible with immunotherapies
Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.
Health IT creates lose-lose situation for physicians
Health IT creates lose-lose situation for physicians
Patients are torn between whether they want their physicians to use technology or not.
Trump attempts market stabilization of Obamacare
Trump attempts market stabilization of Obamacare
What the proposed changes mean to physicians.
Genetic predictors could improve PSA accuracy
A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.
Immunotherapy approved for advanced urothelial Ca
Nivolumab (Opdivo) is the second in class of immune checkpoint inhibitors approved for advanced bladder cancer—treatments that are having “tremendous responses across a spectrum of cancers,” says Leonard G. Gomella, MD.
Everything doctors should know about ICD-10 glitch
Everything doctors should know about ICD-10 glitch
CMS has announced a glitch in the quality reporting measures brought upon by the changes in the ICD-CM (Clinical Modification) and ICD-PCS (Procedural Coding System) updates that went into affect Oct. 1.
Apple looks to expand healthcare presence
Apple looks to expand healthcare presence
The tech giant plans to immerse itself more in healthcare in the years ahead
New study supports MET for larger ureteric stones
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Study examines link between inflammation, prostate Ca
Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.
Obamacare rising costs creating challenges for physicians
Obamacare rising costs creating challenges for physicians
With President-Elect Donald Trump having campaigned vowing to repeal Obamacare, there are some who feel that the federal government’s announcement that premiums for midlevel health plans under the Affordable Care Act are expected to increase by an average of 25% in 2017 is nothing to worry about.